Global Blood Therapeutics
Global Blood Therapeutics
gbt.com

Locations

South San Francisco, CA, USA · United States · San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2011

GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and headquartered in San Francisco, California.

Something looks off?
Open jobs at Global Blood Therapeutics
Powered by Getro